Home Healthcare Healthcare Services Nucleic Acid Therapeutics CDMO Market

Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Cell & Gene Therapies, RNA-based Therapies, mRNA Therapies, siRNA Therapies, Others), By Service (Process Development & Optimization Services, Manufacturing Services, Analytical & Quality Control Services, Others), By End Use (Pharmaceutical & Biotechnology Companies, Government & Academic Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 30, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR4354DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Nucleic Acid Therapeutics CDMO Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Cell & Gene Therapies
    2. RNA-based Therapies
    3. mRNA Therapies
    4. siRNA Therapies
    5. Others
  2. Nucleic Acid Therapeutics CDMO Market, By Service 2022-2034 (USD MILLION/ Units)
    1. Process Development & Optimization Services
    2. Manufacturing Services
    3. Analytical & Quality Control Services
    4. Others
  3. Nucleic Acid Therapeutics CDMO Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical & Biotechnology Companies
    2. Government & Academic Research Institutes
  4. Regional Nucleic Acid Therapeutics CDMO Market
    1. North America
      1. North America Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. North America Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. North America Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. U.S.
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      5. Canada
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
    2. Europe
      1. Europe Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. Europe Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. Europe Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. U.K.
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      5. Germany
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      6. France
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      7. Spain
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      8. Italy
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      9. Russia
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      10. Nordic
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      11. Benelux
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      12. Rest of Europe
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
    3. APAC
      1. APAC Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. APAC Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. APAC Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. China
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      5. Korea
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      6. Japan
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      7. India
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      8. Australia
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      9. Taiwan
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      10. South East Asia
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      11. Rest of Asia-Pacific
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. Middle East and Africa Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. Middle East and Africa Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. UAE
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      5. Turkey
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      6. Saudi Arabia
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      7. South Africa
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      8. Egypt
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      9. Nigeria
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      10. Rest of MEA
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
    5. LATAM
      1. LATAM Nucleic Acid Therapeutics CDMO Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      2. LATAM Nucleic Acid Therapeutics CDMO Market By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      3. LATAM Nucleic Acid Therapeutics CDMO Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
      4. Brazil
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      5. Mexico
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      6. Argentina
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      7. Chile
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      8. Colombia
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
      9. Rest of LATAM
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
        6. Process Development & Optimization Services
        7. Manufacturing Services
        8. Analytical & Quality Control Services
        9. Others
        10. Pharmaceutical & Biotechnology Companies
        11. Government & Academic Research Institutes
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.